Published in Int J Gynecol Cancer on October 01, 2010
Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? Gynecol Oncol (2011) 1.03
The reduced PDCD5 protein is correlated with the degree of tumor differentiation in endometrioid endometrial carcinoma. Springerplus (2016) 0.75
Comparison of Risk Factors and survival of Type 1 and Type II Endometrial Cancers. Pak J Med Sci (2016) 0.75
Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res (2009) 2.32
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update (2013) 1.13
Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? J Immunol (2013) 1.02
Endometrial cancer. BMJ (2011) 1.02
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunol Immunother (2013) 1.01
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses. Gynecol Oncol (2013) 0.94
The poly(c)-binding protein-1 regulates expression of the androgen receptor. Endocrinology (2010) 0.90
A study of symptoms described by ovarian cancer survivors. Gynecol Oncol (2011) 0.86
Dynamic spectral imaging: improving colposcopy. Clin Cancer Res (2009) 0.84
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection. Biomaterials (2013) 0.82
Achieving uterine auto-transplantation in a sheep model using iliac vessel anastomosis: a short-term viability study. Acta Obstet Gynecol Scand (2014) 0.81
The DNA methylomes of serous borderline tumors reveal subgroups with malignant- or benign-like profiles. Am J Pathol (2013) 0.80
Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice. Am J Pathol (2010) 0.79
Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia. Acta Obstet Gynecol Scand (2012) 0.78
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer. Int J Gynecol Cancer (2015) 0.78
Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin. J Immunol (2013) 0.77
A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3. FASEB J (2011) 0.77
A study to evaluate the cause of bone demineralization in gynecological cancer survivors. Oncologist (2013) 0.77
Test of long-term uterine survival after allogeneic transplantation in rabbits. J Obstet Gynaecol Res (2013) 0.76
Dharmasena case illustrates what is wrong with complaints procedures. BMJ (2015) 0.75
Use of cyclosporine in uterine transplantation. J Transplant (2011) 0.75
Referrals to secondary care. Referral rates for postmenopausal bleeding are not respectable. BMJ (2010) 0.75
Uterus transplantation in the human: a complex surgical, medical and ethical challenge. Hum Reprod (2012) 0.75
Is there a role for epigenetic enhancement of immunomodulatory approaches to cancer treatment? Curr Cancer Drug Targets (2017) 0.75
Immunology of uterine transplantation: a review. Reprod Sci (2011) 0.75
Trachelectomy during pregnancy: what has experience taught us? J Obstet Gynaecol Res (2014) 0.75
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. Mol Ther (2017) 0.75
Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours. Int J Gynecol Cancer (2017) 0.75